Turning Point Therapeutics, Inc. EPS - Earnings per Share 2019-2022 | TPTX
Turning Point Therapeutics, Inc. eps - earnings per share from 2019 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Turning Point Therapeutics, Inc. Annual EPS |
| 2021 |
$-4.80 |
| 2020 |
$-3.85 |
| 2019 |
$-2.99 |
| 2018 |
$-7.31 |
| 2017 |
$-4.97 |
| Turning Point Therapeutics, Inc. Quarterly EPS |
| 2022-06-30 |
$-2.48 |
| 2022-03-31 |
$-1.50 |
| 2021-12-31 |
$-1.59 |
| 2021-09-30 |
$-1.34 |
| 2021-06-30 |
$-1.14 |
| 2021-03-31 |
$-0.73 |
| 2020-12-31 |
$-0.92 |
| 2020-09-30 |
$-0.42 |
| 2020-06-30 |
$-0.82 |
| 2020-03-31 |
$-1.69 |
| 2019-12-31 |
$2.31 |
| 2019-09-30 |
$-0.63 |
| 2019-06-30 |
$-0.70 |
| 2019-03-31 |
$-3.97 |
| 2018-12-31 |
$-2.64 |
| 2018-09-30 |
$-1.77 |
| 2018-06-30 |
$-1.49 |
| 2018-03-31 |
$-1.41 |
